Skip to content
Clinical Trials – home
NorwayBack to Norway

Clinical trials in Aalesund – page 3

44 clinical trials in Aalesund, Norway across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

NorwayOur site in NorwayKliniske-Studier.no(opens in a new tab)
Aalesund at a glance
44
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

44 trials in Aalesund

Open in trial search

Cluster headache

Not yet recruiting

A Study of Candesartan Compared to Placebo in Adults with Episodic Cluster Headache to Prevent Severe Headache Attacks

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Candesartan
  • Sponsor:Helse Bergen HF

Ischaemic stroke+2

Not recruiting

Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke

Investigational
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Asundexian
  • Sponsor:Bayer AG

Study of Tozorakimab for Patients with Chronic Obstructive Pulmonary Disease Who Have Symptoms and a History of Flare-ups

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol Sulfate
  • Sponsor:AstraZeneca AB

Plasma cell myeloma

Not recruiting

Study Comparing Belantamab Mafodotin with Lenalidomide and Dexamethasone to Daratumumab with Lenalidomide and Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Belantamab Mafodotin
  • Sponsor:Glaxosmithkline Research & Development Limited

Study on Durvalumab and Stereotactic Body Radiotherapy for Patients with Early-Stage Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Vaestra Goetalandsregionen

Study on Quality of Life in Patients Aged 16-80 with Primary Adrenal Insufficiency Using Hydrocortisone (Plenadren) and Cortisone

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:0–17 years · 18–64 years
  • Substances:Cortisone
  • Sponsor:Helse Bergen HF

Plasma cell myeloma

Not recruiting

Study on Early Treatment for Multiple Myeloma Relapse Using Carfilzomib, Bortezomib, Daratumumab, Lenalidomide, and Dexamethasone in Patients with MRD Negativity

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Oslo University Hospital HF

Cardiac amyloidosis

Not recruiting

Study on the Effectiveness and Safety of ALXN2220 for Adults with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Investigational
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:ALXN2220
  • Sponsor:Alexion Pharmaceuticals Inc.

Study Comparing Subcutaneous and Intravenous Isatuximab with Pomalidomide and Dexamethasone for Adults with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:65+ years
  • Substances:Dexamethasone
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Rheumatoid arthritis

Not recruiting

Study on Monitoring Adalimumab for Maintaining Disease Control in Adults with Rheumatoid Arthritis

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Adalimumab
  • Sponsor:Diakonhjemmet Sykehus AS
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Golimumab
  • Sponsor:Janssen Cilag International

Study on the Effectiveness of Enlicitide Chloride in Reducing Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease

Investigational
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Sponsor:Merck Sharp & Dohme LLC

Other cities in Norway

The busiest research cities in the country

All 54 cities in Norway

Clinical research in Aalesund

What the registry says about research in the country

01 Oncology Research

Clinical investigations focusing on multiple myeloma, rare cancers, and innovative treatments for lung cancer. Studies evaluate targeted therapies and combination treatments to improve patient outcomes.

  • Multiple Myeloma Treatment Studies
  • Precision Medicine in Rare Cancers
  • Small-Cell Lung Cancer Therapy

Emphasis on developing personalized treatment approaches and evaluating novel drug combinations.

02 Cardiovascular Studies

Research focused on preventing stroke and managing cardiovascular conditions. Trials evaluate new medications for stroke prevention and heart rhythm disorders.

  • Stroke Prevention Therapies
  • Atrial Fibrillation Management
  • Cardiovascular Risk Reduction

Advanced treatments aimed at reducing cardiovascular events and improving patient outcomes.

03 Inflammatory Conditions

Studies examining treatments for Crohn's Disease and rheumatoid arthritis. Research focuses on innovative therapies and drug monitoring approaches.

  • Autoimmune Disease Management
  • Therapeutic Drug Monitoring
  • Inflammatory Disease Treatments

Investigation of targeted therapies and treatment optimization strategies.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.